Crescent Biopharma, Inc.

NEW YORK, May 7, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating:

• GlycoMimetics, Inc. (NASDAQ: GLYC), relating to a proposed merger with First Crescent Biopharma, Inc. Under the terms of the agreement, pre-acquisition GlycoMimetics stockholders are expected to own approximately 3.1% of the combined Company.

Click here for more information https://monteverdelaw.com/case/glycomimetics-inc-glyc/. It is free and there is no cost or obligation to you.

• Breeze Holdings Acquisition Corp. (OTC: BRZH), relating to its proposed merger with YD Biopharma Limited. Under the terms of the agreement, all Breeze Holdings ordinary shares will be converted into the right to receive one ordinary share of the surviving company. 

Click here for more information: https://monteverdelaw.com/case/breeze-holdings-acquisition-corp-2/. It is free and there is no cost or obligation to you.

• ProAssurance Corporation (NYSE: PRA), relating to the proposed merger with The Doctors Company. Under the terms of the agreement, ProAssurance stockholders will receive $25.00 per share in cash.

Click here for more https://monteverdelaw.com/case/proassurance-corporation-pra/. It is free and there is no cost or obligation to you.

• Future Vision II Acquisition Corp. (NASDAQ: FVNNU), relating to the proposed merger with Viwo Technology Inc. Under the terms of the agreement, Viwo shareholders will receive in the aggregate 9,950,250 shares of Future Vision valued at $10.05 per share.

Click here for more https://monteverdelaw.com/case/future-vision-ii-acquisition-corp-fvnnu/. It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

1. Do you file class actions and go to Court?
2. When was the last time you recovered money for shareholders?
3. What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No company, director or officer is above the law. If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan Monteverde, Esq.

MONTEVERDE & ASSOCIATES PC

The Empire State Building

350 Fifth Ave. Suite 4740

New York, NY 10118

United States of America

jmonteverde@monteverdelaw.com

Tel: (212) 971-1341

Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

View original content to download multimedia:https://www.prnewswire.com/news-releases/tockholder-alert-the-ma-class-action-firm-continues-its-investigation-into-the-merger--glyc-brzh-pra-fvnnu-302449232.html

SOURCE Monteverde & Associates PC

NEW YORK, May 7, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Columbia Banking System, Inc. (NASDAQ: COLB)'s merger with Pacific Premier Bancorp, Inc. Upon closing of the proposed transaction, Columbia shareholders will own approximately 70% of Columbia's outstanding shares of common stock. If you are a Columbia shareholder, click here to learn more about your rights and options.

ProAssurance Corporation (NYSE: PRA)'s sale to The Doctors Company for $25.00 in cash per share. If you are a ProAssurance shareholder, click here to learn more about your rights and options.

GlycoMimetics, Inc. (NASDAQ: GLYC)'s merger with Crescent Biopharma, Inc. Upon closing of the proposed transaction, GlycoMimetics stockholders are expected to own approximately 3.1% of the combined company. If you are a GlycoMimetics shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-colb-pra-glyc-on-behalf-of-shareholders-302448616.html

SOURCE Halper Sadeh LLP